Semaglutide and SGLT2 Inhibitors at EASD 2024: Insights into Cardiovascular Benefits and Challenges
Explore the latest EASD 2024 findings on semaglutide’s heart health benefits and challenges with SGLT2 inhibitors in diabetes management.
This category covers various less common diabetes types, including Wolfram Syndrome, Alstrom Syndrome, Latent Autoimmune Diabetes in Adults (LADA), Steroid-Induced Diabetes, and Cystic Fibrosis Diabetes. It includes causes, symptoms, diagnosis, and treatment.
Explore the latest EASD 2024 findings on semaglutide’s heart health benefits and challenges with SGLT2 inhibitors in diabetes management.
Discover how Latent Autoimmune Diabetes in Adults (LADA) complicates diabetes diagnosis by mimicking both Type 1 and Type 2 symptoms.
Explore the link between Retinal Dystrophy and Alstrom Syndrome. Learn about symptoms, treatment options, and their impact on vision and health.
Discover why DIDMOAD is a complex condition affecting multiple body systems, making diagnosis and treatment challenging.
Discover how stem cell-derived therapies can regenerate insulin-producing cells and offer new hope for Type 1 diabetes treatment.
Explore how Metformin may impact Long Covid symptoms, with research highlighting its potential to reduce risk and improve recovery outcomes.
Could nitric oxide hold the key to a diabetes cure? Learn how its role in insulin production could revolutionize Type 2 diabetes treatment options.